Ironic’s proteins are produced through precision fermentation and are used as ingredients in food or food supplements.
Ironic Biotech has raised €1.0M across 1 funding round, most recently a Pre-Seed round in Apr 2024. Based in Stockholm, Sweden; active in Foodtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-04-04 | Pre-Seed | €1.0M |
| — |
| View deal → |
